SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-032543
Filing Date
2021-02-08
Accepted
2021-02-08 17:30:26
Documents
5
Effectiveness Date
2021-02-08

Document Format Files

Seq Description Document Type Size
1 S-8 d120409ds8.htm S-8 86094
2 EX-5.1 d120409dex51.htm EX-5.1 13301
3 EX-23.2 d120409dex232.htm EX-23.2 2055
4 GRAPHIC g120409dsp16.jpg GRAPHIC 5176
5 GRAPHIC g120409g0209001849464.jpg GRAPHIC 1843
  Complete submission text file 0001193125-21-032543.txt   112438
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252862 | Film No.: 21602714
SIC: 2836 Biological Products, (No Diagnostic Substances)